Publications

5674 Results

Updated analysis of SWOG 0023: a randomized phase III trial of gefitinib versus placebo maintenance after definitive chemoradiation followed by docetaxel in patients with locally advanced stage III non-small cell lung cancer

Authors
K Kelly;K Chansky;LE Gaspar;JR Jett;Y Ung;KS Albain;JJ Crowley;DR Gandara
Journal / Conference
Proc of the American Society of Clinical Oncology, Journal of Clinical Oncology 25(18S):#7513
Year
2007
Research Committee(s)
Lung
Study Number(s)
S0023

Cisplatin (Cis)/etoposide (VP16) compared to cis/irinotecan (CPT11) in extensive-stage small cell lung cancer (E-SCLC): pharmacogenomic (PG) and comparative toxicity analysis of JCOG 9511 and SWOG 0124

Authors
P Lara Jr;M Redman;H Lenz;M Gordon;T Shibata;H Fukuda;T Tamura;N Saijo;R Natale;DR Gandara
Journal / Conference
Proc of the American Society of Clinical Oncology, Journal of Clinical Oncology 25(18S):#7524
Year
2007
Research Committee(s)
Lung
Study Number(s)
S0124

Phase III randomized trial of pegylated liposomal doxorubicin (PLD) plus carboplatin versus carboplatin in platinum-sensitive (PS) patients with recurrent epithelial ovarian or peritoneal carcinoma after failure of initial platinum-based chemotherapy: Southwest Oncology Group Protocol S0200

Authors
DS Alberts;PY Liu;S Wilczynski;M Clouser;A Lopez;M Lange;V Lanzotti;M Markman
Journal / Conference
Proc of the American Society of Clinical Oncology, Journal of Clinical Oncology 25(18S):#5551
Year
2007
Research Committee(s)
Gynecologic
Study Number(s)
S0200

Phase III study of gemcitabine (G) plus cetuximab (C) versus gemcitabine in patients (pts) with locally advanced or metastatic pancreatic adenocarcinoma (PC): SWOG S0205 study

Authors
PA Philip;J Benedetti;C Fenoglio-Preiser;M Zalupski;H Lenz;E O'Reilly;R Wong;J Atkins;J Abbruzzese;C Blanke
Journal / Conference
Proc of the American Society of Clinical Oncology, Journal of Clinical Oncology 25(18S):#LBA4509
Year
2007
Research Committee(s)
Gastrointestinal
Study Number(s)
S0205

S0216: a Southwest Oncology Group (SWOG) phase II trial of docetaxel (T), cisplatin (P), and fluorouracil (F) induction followed by accelerated fractionation/concomitant boost (AF/CB) radiotherapy (RT) and concurrent cisplatin for advanced head and neck squamous cell cancer (HNSCC)

Authors
DJ Adelstein;J Moon;E Hanna;SPG Giri;GM Mills;GT Wolf;SG Urba
Journal / Conference
Proc of the American Society of Clinical Oncology, Journal of Clinical Oncology 25(18S):#6014
Year
2007
Research Committee(s)
Head and Neck
Study Number(s)
S0216

A phase II study of IV gemcitabine (G) and oral capecitabine (C) in patients (pts) with advanced renal cell cancer (RCC): results of Southwest Oncology Group study 0312

Authors
PJ Van Veldhuizen;M Hussey;PN Lara;PH Gumerlock;J Clark;MK Lange;D Crawford
Journal / Conference
Proc of the American Society of Clinical Oncology, Journal of Clinical Oncology 25(18S):#15562
Year
2007
Research Committee(s)
Genitourinary
Study Number(s)
S0312

Phase II trial of the epidermal growth factor receptor (EGFR) inhibitor erlotinib (E) in patients (pts) with advanced papillary renal cell carcinoma (pRCC)--SWOG S0317

Authors
C Pan;M Hussey;P Lara;PC Mack;RB Nagle;J Dutcher;W Samlowski;J Clark;ED Crawford;MS Gordon
Journal / Conference
Proc of the American Society of Clinical Oncology, Journal of Clinical Oncology 25(18S):#15516
Year
2007
Research Committee(s)
Genitourinary
Study Number(s)
S0317

Erlotinib as initial therapy in patients with advanced non-small cell lung cancer (NSCLC) and a performance status (PS) of 2: A SWOG phase II trial (S0341)

Authors
PJ Hesketh;K Chansky;AJ Wozniak;P Mack;PN Lara;WA Franklin;FR Hirsch;J Crowley;DR Gandara
Journal / Conference
Proc of the American Society of Clinical Oncology, Journal of Clinical Oncology 25(18S):#7536
Year
2007
Research Committee(s)
Lung
Study Number(s)
S0341

A phase II randomized selection trial evaluating concurrent chemotherapy plus cetuximab or chemotherapy followed by cetuximab in patients with advanced non-small cell lung cancer (NSCLC): final report of SWOG 0342

Authors
RS Herbst;K Chansky;K Kelly;JN Atkins;AM Davies;SR Dakhil;KS Albain;ES Kim;JJ Crowley;DR Gandara
Journal / Conference
Proc of the American Society of Clinical Oncology, Journal of Clinical Oncology 25(18S):#7545
Year
2007
Research Committee(s)
Lung
Study Number(s)
S0342

Clinical and molecular factors predictive of outcome with first-line sorafenib-based therapy in advanced renal carcinoma (RCC): an analysis of SWOG 0412

Authors
BH Goldman;PN Lara Jr;TM Beer;PC Mack;HA Drabkin;WS Holland;ED Crawford;CW Ryan
Journal / Conference
Proc of the American Society of Clinical Oncology, Journal of Clinical Oncology 25(18S):#5108
Year
2007
Research Committee(s)
Genitourinary
Study Number(s)
S0412